Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment
- PMID: 11895892
Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment
Comment on
-
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.Clin Cancer Res. 2002 Mar;8(3):718-28. Clin Cancer Res. 2002. PMID: 11895901 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical